Cost effectiveness of losartan in patients with hypertension and LVH: an economic evaluation for Sweden of the LIFE trial.
2005 (English)In: J Hypertens, ISSN 0263-6352, Vol. 23, no 7, 1425-31 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2005. Vol. 23, no 7, 1425-31 p.
Aged, Antihypertensive Agents/*economics/therapeutic use, Atenolol/economics/therapeutic use, Clinical Trials as Topic, Cost-Benefit Analysis, Double-Blind Method, Electrocardiography, Female, Humans, Hypertension/complications/diagnosis/drug therapy/*economics, Hypertrophy; Left Ventricular/*complications/diagnosis/drug therapy/*economics, Losartan/*economics/therapeutic use, Male, Middle Aged, National Health Programs/*economics, Quality of Life, Quality-Adjusted Life Years, Randomized Controlled Trials as Topic, Risk Factors, Stroke/prevention & control, Sweden, Treatment Outcome
IdentifiersURN: urn:nbn:se:umu:diva-6263PubMedID: 15942467OAI: oai:DiVA.org:umu-6263DiVA: diva2:145932